Benefits of a survey relating to the use of Epidiolex (cannabidiol) oral alternative in sufferers with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) signifies enhancement in affected individual results. Dravet and Lennox-Gastaut syndromes are scarce conditions showing throughout the initially year of lifetime, characterised by recurrent fever-similar seizures. These seizures…